Journal Title：Pharmacoepidemiology And Drug Safety

The aim of Pharmacoepidemiology and Drug Safety is to provide an international forum for the communication and evaluation of data, methods and opinion in the discipline of pharmacoepidemiology. The Journal publishes peer-reviewed reports of original research, invited reviews and a variety of guest editorials and commentaries embracing scientific, medical, statistical, legal and economic aspects of pharmacoepidemiology and post-marketing surveillance of drug safety. Appropriate material in these categories may also be considered for publication as a Brief Report.

Particular areas of interest include:

design, analysis, results, and interpretation of studies looking at the benefit or safety of specific pharmaceuticals, biologics, or medical devices, including studies in pharmacovigilance, postmarketing surveillance, pharmacoeconomics, patient safety, molecular pharmacoepidemiology, or any other study within the broad field of pharmacoepidemiology;

comparative effectiveness research relating to pharmaceuticals, biologics, and medical devices. Comparative effectiveness research is the generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition, as these methods are truly used in the real world;

methodologic contributions of relevance to pharmacoepidemiology, whether original contributions, reviews of existing methods, or tutorials for how to apply the methods of pharmacoepidemiology;

assessments of harm versus benefit in drug therapy;

patterns of drug utilization;

relationships between pharmacoepidemiology and the formulation and interpretation of regulatory guidelines;

evaluations of risk management plans and programmes relating to pharmaceuticals, biologics and medical devices.

《藥物流行病學與藥物安全》旨在為藥物流行病學領域的數(shù)據(jù)、方法和觀點的交流與評估提供一個國際論壇。該期刊發(fā)表同行評審的原創(chuàng)研究報告、受邀評論以及各種客座社論和評論，涵蓋藥物流行病學和藥物安全上市后監(jiān)測的科學、醫(yī)學、統(tǒng)計、法律和經(jīng)濟方面。這些類別中的適當材料也可考慮作為簡報發(fā)表。

特別感興趣的領域包括：

研究特定藥物、生物制劑或醫(yī)療器械的益處或安全性的研究的設計、分析、結果和解釋，包括藥物警戒、上市后監(jiān)測、藥物經(jīng)濟學、患者安全、分子藥物流行病學或藥物流行病學廣泛領域內的任何其他研究；

與藥物、生物制劑和醫(yī)療器械有關的比較有效性研究。比較效果研究是生成和綜合證據(jù)，比較預防、診斷、治療和監(jiān)測臨床狀況的替代方法的益處和危害，因為這些方法確實在現(xiàn)實世界中使用；

與藥物流行病學相關的方法學貢獻，無論是原創(chuàng)貢獻、現(xiàn)有方法的評論，還是如何應用藥物流行病學方法的教程；

藥物治療中的危害與益處評估；

藥物使用模式；

藥物流行病學與監(jiān)管指南的制定和解釋之間的關系；

與藥品、生物制劑和醫(yī)療器械有關的風險管理計劃和方案的評估。

Pharmacoepidemiology And Drug Safety創(chuàng)刊于1992年，由John Wiley and Sons Ltd出版商出版，收稿方向涵蓋醫(yī)學 - 藥學全領域，此期刊水平偏中等偏靠后，在所屬細分領域中專業(yè)影響力一般，過審相對較易，如果您文章質量佳，選擇此期刊，發(fā)表機率較高。平均審稿速度 約3月 ，影響因子指數(shù)2.4，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。